14th Annual Cardiovascular Disease Update: TRACK THREE
14th Annual Cardiovascular Disease Update:
TRACK THREE: EMERGING APPROACHES TO CARDIOVASCULAR PREVENTION
[Non-CME eligible education program]
Cardiovascular disease is the leading cause of death in the United States for both men and women. Treatment approaches are helping prolong life with improved quality in many patients with advanced heart disease. This symposium will provide an in-depth review of current advances in the care of complex patients with cardiovascular disease. Practitioners should be able to incorporate many of the tips and tools from this case-based program into their daily practice.
The following educational presentations were part of the original CME program presented by University Hospitals Harrington Heart & Vascular Institute and sponsored by Case Western Reserve University School of Medicine on October 9, 2021. All speakers are faculty of University Hospitals Cleveland Medical Center unless otherwise noted.
Are Fish Oils Useful, and If So, Which One?
In this presentation, Anand Rohatgi, MD, discusses the use of fish oils and the benefits.
SGLT2 Inhibitors: A Practical Guide for the Primary Care Physicians
In this presentation, Ildiko Lingvay, MD, discusses the use of SGLT2 Inhibitors for primary care physicians.
GLP-1 Agonists to Reduce Cardiovascular Disease: How, When and Which?
In this presentation, Ian Neeland, MD, discusses the use of GLP-1 agonists to reduce cardiovascular disease.